June. 13, 2018 |
|
Dec. 17, 2020 |
|
jRCT2080223943 |
An Open-label Study to Assess the Effect of JTT-751 as Iron Replacement Therapy in Patients with Iron Deficiency Anemia |
|
An open-label study in patients with iron deficiency anemia |
Dec. 25, 2019 |
|
73 |
|
Baseline characteristcs did not differ significantly between groups. |
|
Total of 73 patients were enrolled. |
|
JTT-751 showed a favorable tolerability profile. |
|
Serum ferritin levels increased after the start of treatment with JTT-751. |
|
The time profiles of iron-related test values showed an improvement in the iron-deficient state associated with JTT-751 treatment. |
|
The efficacy and safety of JTT-751 were confirmed in patients with iron deficiency anemia. |
|
Undecided |
|
version: date: |
Japan Tobacco Inc. |
||
clinicaltrials-info-j@jt.com |
Japan Tobacco Inc. |
||
clinicaltrials-info-j@jt.com |
completed |
July. 25, 2018 |
||
70 | ||
Interventional |
||
Multi-center, Uncontrolled, Open-label study |
||
treatment purpose |
||
3 |
||
Iron deficiency anemia |
||
* Anemia caused by other than iron deficiency |
||
20age old over | ||
No limit | ||
Both |
||
Iron Deficiency Anemia |
||
investigational material(s) |
||
efficacy |
||
efficacy |
Japan Tobacco Inc. | |
- |
Torii Pharmaceutical Co.,Ltd. | |
- |
Review Board of Human Rights and Ethics for Clinical Studies Institutional Review Board | |
13-2 Ichibancho, Chiyoda-ku, Tokyo | |
approved | |
July. 20, 2018 |
JapicCTI-184000 | |
Japan |